Alvotech rated Hold after FDA setback for AVT05. Click for my look at ALVO stock prospects and what would make me upgrade it ...
FDA recently issued the draft guidance, Quality Management System Information for Certain Premarket Submission Reviews. The guidance is designed ...
While the FDA continues to put out guidance documents and approve drugs, some companies are already reporting delays in ...
Shares of Alvotech (NASDAQ: ALVO) fell 22% on Monday after the U.S. Food and Drug Administration (FDA) issued a Complete ...
As the festive season fills markets with colourful sweets and tempting snacks, the FDA has launched a massive food safety ...
Total GAAP operating expenses of $115.3 million for the third quarter 2025 increased by 8% as compared to $106.6 million for the third quarter 2024. Total non-GAAP operating expenses 2 were up 15% to ...
As the festive season fills markets with colourful sweets and tempting snacks, the Maharashtra FDA) has launched a massive ...
TipRanks on MSN
FDA’s ‘surprising’ uniQure reversal drags down Biohaven
Shares of BioHaven (BHVN) are sliding on Monday after uniQure (QURE) announced that the Food and Drug Administration no longer agrees AMT-130 data ...
Part one of a two-part series on FDA Commissioner Martin Makary, M.D.s comments at the Gailen Forum in New York City on October 30, 2025.
Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter 2024Dupixent® global net sales(recorded by Sanofi) increased 27% ...
Regeneron posts Q3 earnings of $11.83 per share, topping estimates as Dupixent profits lift results despite weaker Eylea ...
Recursion, Roche and Genentech unveiled the latest product of their nearly four-year artificial intelligence drug discovery collaboration. GSK ’s Blenrep was approved by the FDA for treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback